Philip C Prorok

No ORCID on file · 2 papers in corpus
rct 2016
Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.08.334

BACKGROUND: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial originally reported no mortality benefit of ovarian cancer screening after a median of 12.4years of follow-up. The UKCTOCS screening trial failed to show a…

rct 2012
Gynecologic Oncology ·doi:10.1016/j.ygyno.2011.12.440

OBJECTIVE: To determine whether CA-125 velocity is a statistically significant predictor of ovarian cancer and develop a classification rule to screen for ovarian cancer. METHODS: In the ovarian component of the PLCO cancer screening trial…